Objective:: Determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents.
Method:: Analysis of original articles retrieved from the following databases: LILACS, PubMed, Cochrane Controlled Trials Clinical Data Bank (CENTRAL) and PsycINFO, without language restriction, dated until November 2015. After screening of 2,812 studies, three cohort original articles were selected for quality analysis.